08:45:47 EDT Sun 16 Jun 2019
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 18 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-06-16 08:00RICKNews ReleaseROSEN, A HIGHLY RANKED LAW FIRM, Reminds RCI Hospitality Holdings, Inc. Investors of Lead Plaintiff Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – RICK
2019-06-16 08:00LLLNews ReleaseL3 Introduces Production-Ready C-130 Avionics Modernization Solution for International C-130 Platforms
2019-06-16 08:00LLLNews ReleaseL3 Achieves Record-High ISR Sensors Orders
2019-06-16 06:21SNews ReleaseSprint Shareholder Litigation: Block & Leviton LLP Encourages Shareholders To Contact The Firm
2019-06-16 02:40ESLTNews ReleaseElbit Systems Awarded $50 Million Contract to Supply Structural Parts fromComposite Materials for an Aircraft of a Customer in North America
2019-06-16 02:00AMGNNews ReleaseAmgen Announces BLINCYTO ® (blinatumomab) Five-Year Overall Survival Data At EHA 2019
2019-06-16 01:00CUBNews ReleaseCubic to Showcase Multi-Domain LVC Advanced Training Environment for Fighter Pilots at International Paris Air Show 2019
2019-06-15 16:15LMTNews ReleaseLittoral Combat Ship 21 (Minneapolis-Saint Paul) Christened and Launched
2019-06-15 14:39PBFXNews ReleasePBF Energy to Attend the J.P. Morgan 2019 Energy Conference
2019-06-15 14:39PBFNews ReleasePBF Energy to Attend the J.P. Morgan 2019 Energy Conference
2019-06-15 14:00REVNews ReleaseREV DEADLINE: Rosen, a Highly Ranked Law Firm, Reminds Revlon, Inc. Investors of Important July 15th Deadline in Securities Class Action – REV
2019-06-15 13:53SILKNews ReleaseROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile
2019-06-15 13:45CNINews ReleaseTeamsters Rail Traffic Controllers Ratify New CN Agreement
2019-06-15 11:30SNSSNews ReleaseSunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual Meeting
2019-06-15 11:30EDITNews ReleaseEditas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
2019-06-15 10:00APLSNews ReleaseApellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress
2019-06-15 09:30AAPLNews ReleaseLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Apple, Inc. To Contact The Firm
2019-06-15 09:00FTSVNews ReleaseForty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin ’s Lymphoma